Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer

Treatment of adult short bowel syndrome patients with teduglutide

(2012) Lærke Marijke Nørholk et al.   EXPERT OPINION ON PHARMACOTHERAPY

The “cryptic” mechanism of action of glucagon-like peptide-2

(2011) Katherine J. Rowland et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse

(2011) Anna Merlos-Suárez et al.   Cell Stem Cell

Role of intestinal inflammation as an early event in obesity and insulin resistance

(2011) Shengli Ding et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Intestinal Inflammation and Cancer

(2011) Thomas A. Ullman et al.   GASTROENTEROLOGY

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

(2011) P. B. Jeppesen et al.   GUT

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

(2011) Lasse Bremholm et al.   REGULATORY PEPTIDES

ErbB Activity Links the Glucagon-Like Peptide-2 Receptor to Refeeding-Induced Adaptation in the Murine Small Bowel

(2010) Jasmine Bahrami et al.   GASTROENTEROLOGY

Cell cycle control of mammalian neural stem cells: putting a speed limit on G1

(2010) Paolo Salomoni et al.   TRENDS IN CELL BIOLOGY

Carcinogenic Effects of Exogenous and Endogenous Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice

(2009) Roman Iakoubov et al.   ENDOCRINOLOGY

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease

(2009) Alan L. Buchman et al.   INFLAMMATORY BOWEL DISEASES

Doublecortin and CaM Kinase-like-1 and Leucine-Rich-Repeat-Containing G-Protein-Coupled Receptor Mark Quiescent and Cycling Intestinal Stem Cells, Respectively

(2009) Randal May et al.   STEM CELLS

Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2

(2008) Catherine P. A. Ivory et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Glucagon-like Peptide-2 Does Not Modify the Growth or Survival of Murine or Human Intestinal Tumor Cells

(2008) J. A. Koehler et al.   CANCER RESEARCH

Mouse models for the study of colon carcinogenesis

(2008) D. W. Rosenberg et al.   CARCINOGENESIS

Crypt stem cells as the cells-of-origin of intestinal cancer

(2008) Nick Barker et al.   NATURE

Glucagon-Like Peptide-2 Activates β-Catenin Signaling in the Mouse Intestinal Crypt: Role of Insulin-Like Growth Factor-I

(2007) Philip E. Dubé et al.   ENDOCRINOLOGY

Identification of a Novel Putative Gastrointestinal Stem Cell and Adenoma Stem Cell Marker, Doublecortin and CaM Kinase-Like-1, Following Radiation Injury and in Adenomatous Polyposis Coli/Multiple Intestinal Neoplasia Mice

(2007) Randal May et al.   STEM CELLS